CSO Exam 170 questions 2025
with Complete Solutions
Graded A+
QUESTIONS AND ANSWERS
Ageusia. ANSWER -Loss or absence of the sense of taste
Allogenic marrow transplantation. ANSWER -Transfer of marrow from donor to
another person who is not genetically identical
Antineoplastic agents. ANSWER -Chemical agents (cytotoxics, immuniologic
preparations, hormones) or meds used to prevent the development, maturation or
spread of neoplastic cells
antioxidants. ANSWER -molecules (ie. vitamins) that blcok action of activated
oxygen molecules (free radicals) that can demage cells
antologous marrow transplantation. ANSWER -transfer of marrow from the pt's own
tissue (from hematopietic stem cells)
cancer cachexia. ANSWER -wt loss, anorexia, wasting, immunosuppression, altered
BMR, abnormalitis in fluid & energy metabolism, lessening of the body's fat & muscle
stores that accompanies advanced CA even with adequate nutrition.
,carcinogen. ANSWER -an agent (physical, chemical, or viral) that induces CA
carcinogenesis. ANSWER -the origin or development of CA, a multistage, biological
process that proceeds on a continuum but is often described in stages of initiation,
promotion and progression
cytokines. ANSWER -protein mediators produced by inflammatory cells in response
to exogenous stimuli, produce metabolic changes & wating
dysgeusia. ANSWER -impaired taste
graft-versus-host disease (GVHD). ANSWER -a dz caused by the immune response of
histoincompatible, immunocompetent donor cells against the tissues of an
immunoincompetent host; an immuniologic reaction of allogeneic donor cells (graft)
reacting against the pt (host) tissues
evidenced by icterus & abnormal liver functions, severe /secretory diarrhea - may
need total bowel rest --> isomotic, low residue, lactose-free diet --> solids with low
lactose, fiber, fat & acideity, gastric irritants --> regular diet
- usually 3 onths after transplant (but may be 7-10 days post)
hypogeusia. ANSWER -decreased taste acuity
initiation. ANSWER -the initial stage of tumorigenesis, involving transformation of
cellular DNA
malignant neoplasm. ANSWER -mass of CA cells that invades surrounding tissues or
spreads to distant areas of body
, metastasis. ANSWER -growth of malignant tissue that spreads to surrounding tissue
or organs
myelosuppression. ANSWER -suppression of bone marrow cell production
neutropenia. ANSWER -a reduction of WBC (neutrophils) that can be caused by
chemo or XRT, results in increased susceptibility to life-threatening infections
pancytopenia. ANSWER -a reduction in all cellular elements of the blood
phytochemicals. ANSWER -nonutritive compounds in plants though to influence the
process of tumorigenesis
progression. ANSWER -the phase in which tumor cells aggregate, grow
autonomously and form benign tumors that eventually lead to malignant phenotype
with the capacity for tissue invasion & mets
Promotion. ANSWER -The stage of tumorigenesis in which initiated cells are
activated by a promoting agent to multiply and form a discrete tumor
radiation-induced enteritis. ANSWER -a condition of inflammation that can occur
after XRT to the GI tract & that leads to diarrhea & malabsorption
with Complete Solutions
Graded A+
QUESTIONS AND ANSWERS
Ageusia. ANSWER -Loss or absence of the sense of taste
Allogenic marrow transplantation. ANSWER -Transfer of marrow from donor to
another person who is not genetically identical
Antineoplastic agents. ANSWER -Chemical agents (cytotoxics, immuniologic
preparations, hormones) or meds used to prevent the development, maturation or
spread of neoplastic cells
antioxidants. ANSWER -molecules (ie. vitamins) that blcok action of activated
oxygen molecules (free radicals) that can demage cells
antologous marrow transplantation. ANSWER -transfer of marrow from the pt's own
tissue (from hematopietic stem cells)
cancer cachexia. ANSWER -wt loss, anorexia, wasting, immunosuppression, altered
BMR, abnormalitis in fluid & energy metabolism, lessening of the body's fat & muscle
stores that accompanies advanced CA even with adequate nutrition.
,carcinogen. ANSWER -an agent (physical, chemical, or viral) that induces CA
carcinogenesis. ANSWER -the origin or development of CA, a multistage, biological
process that proceeds on a continuum but is often described in stages of initiation,
promotion and progression
cytokines. ANSWER -protein mediators produced by inflammatory cells in response
to exogenous stimuli, produce metabolic changes & wating
dysgeusia. ANSWER -impaired taste
graft-versus-host disease (GVHD). ANSWER -a dz caused by the immune response of
histoincompatible, immunocompetent donor cells against the tissues of an
immunoincompetent host; an immuniologic reaction of allogeneic donor cells (graft)
reacting against the pt (host) tissues
evidenced by icterus & abnormal liver functions, severe /secretory diarrhea - may
need total bowel rest --> isomotic, low residue, lactose-free diet --> solids with low
lactose, fiber, fat & acideity, gastric irritants --> regular diet
- usually 3 onths after transplant (but may be 7-10 days post)
hypogeusia. ANSWER -decreased taste acuity
initiation. ANSWER -the initial stage of tumorigenesis, involving transformation of
cellular DNA
malignant neoplasm. ANSWER -mass of CA cells that invades surrounding tissues or
spreads to distant areas of body
, metastasis. ANSWER -growth of malignant tissue that spreads to surrounding tissue
or organs
myelosuppression. ANSWER -suppression of bone marrow cell production
neutropenia. ANSWER -a reduction of WBC (neutrophils) that can be caused by
chemo or XRT, results in increased susceptibility to life-threatening infections
pancytopenia. ANSWER -a reduction in all cellular elements of the blood
phytochemicals. ANSWER -nonutritive compounds in plants though to influence the
process of tumorigenesis
progression. ANSWER -the phase in which tumor cells aggregate, grow
autonomously and form benign tumors that eventually lead to malignant phenotype
with the capacity for tissue invasion & mets
Promotion. ANSWER -The stage of tumorigenesis in which initiated cells are
activated by a promoting agent to multiply and form a discrete tumor
radiation-induced enteritis. ANSWER -a condition of inflammation that can occur
after XRT to the GI tract & that leads to diarrhea & malabsorption
